Corbus International Limited
11195935
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
28/02/2025
total exemption full
Next accounts due
30/11/2026
Confirmation statement
Last: 07/02/2026
Due 21/02/2027
Industry
Officers
director · Since 10/10/2022
VICE PRESIDENT CLINICAL OPERATIONS AND
BRITISH · UNITED KINGDOM · Age 54
Also on 1 other board
director · Since 27/02/2024
CHIEF MEDICAL OFFICER
BRITISH · UNITED KINGDOM · Age 53
Also on 3 other boards
corporate secretary · Since 08/02/2018
Reg: 04328885
Also on 1085 other boards
Former
corporate director · Resigned 08/02/2018
corporate director · Resigned 08/02/2018
director · Resigned 12/07/2021
director · Resigned 30/09/2022
Persons with Significant Control
Corbus Pharmaceuticals, Holdings, Inc.
500, River Ridge Drive, Norwood, 02062
Reg: 464348039 · Massachusetts · Corporate
Notified 08/02/2018
Change History
Active
Private Limited Company
5 NEW STREET SQUARE
LONDON
CompanyRankvs 21064+ SIC 82990 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 28/02/2023
Net Worth
£3.5M
Balance sheet strength
Cash
£1.7M
Cash in the bank
Net Current Assets
£3.5M
Working capital
Current Assets
£5.8M
Current Liabilities
£2.4M
Debtors
£4.2M
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2023 | 2.47 |
Derived from filed accounts. Not audited figures.
Filing History28 filings
accounts with accounts type total exemption full
confirmation statement with updates
capital allotment shares
confirmation statement with updates
change person director company with change date
capital allotment shares
accounts with accounts type total exemption full
appoint person director company with name date
confirmation statement with updates
capital allotment shares
accounts with accounts type total exemption full
confirmation statement with no updates
appoint person director company with name date
termination director company with name termination date
accounts with accounts type total exemption full
confirmation statement with no updates
termination director company with name termination date
accounts with accounts type unaudited abridged
confirmation statement with no updates
accounts with accounts type unaudited abridged
confirmation statement with no updates
accounts with accounts type total exemption full
confirmation statement with updates
appoint person director company with name date
appoint person director company with name date
termination director company with name termination date
termination director company with name termination date
incorporation company